Verified peer comparison
Gilead Sciences vs Novartis Financial Comparison
Direct answer
Gilead Sciences and Novartis are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Gilead Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Gilead Sciences Revenue
- 29,442,000,000 USD
- Novartis Revenue
- 54,811,252,000 USD
- Gilead Sciences Operating income
- 11,701,000,000 USD
- Novartis Operating income
- 17,073,989,000 USD